The Schwab US Dividend Equity ETF (SCHD) has an implied analyst target price of $29.85 per unit, suggesting a 10.46% upside from its current trading price of $27.02. This analysis is based on the ETF’s underlying holdings.
Several underlying holdings show notable upside: Halliburton Company (HAL) is projected to rise 34.01% from its recent price of $21.22 to an average target of $28.44; Kimberly-Clark Corp. (KMB) may see an 11.00% increase from $127.53 to $141.56; and AbbVie Inc. (ABBV) has an expected 10.87% surge from $189.26 to $209.84.
Combined, these three companies represent 6.28% of SCHD’s portfolio. Investors should consider whether current analyst targets are justified based on company and industry developments.
